Chemotherapy of experimental keratomycosis.
D000666:Amphotericin B / Q000008:administration & dosage; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage*; D001230:Aspergillus / Q000187:drug effects; D001548:Benzalkonium Compounds / Q000008:administration & dosage; D002175:Candida / Q000187:drug effects; D003300:Copper / Q000008:administration & dosage; D003320:Corneal Ulcer / Q000188:drug therapy; D003907:Dexamethasone / Q000008:administration & dosage; D004357:Drug Synergism; D007267:Injections; D007500:Iritis / Q000188:drug therapy; D007634:Keratitis / Q000188:drug therapy*; D009181:Mycoses / Q000188:drug therapy*; D009761:Nystatin / Q000008:administration & dosage; D009883:Ophthalmic Solutions; D011193:Potassium Iodide / Q000008:administration & dosage; D011725:Pyridines / Q000008:administration & dosage; D011817:Rabbits; D013431:Sulfates / Q000008:administration & dosage
D000935:Antifungal Agents; D001548:Benzalkonium Compounds; D009883:Ophthalmic Solutions; D011725:Pyridines; D013431:Sulfates; D009761:Nystatin; D011193:Potassium Iodide; D003300:Copper; D003907:Dexamethasone; D000666:Amphotericin B